policy

Meet Dr. Renee Wegrzyn, the first Director of President Biden's new health agency, ARPA-H

Podcast Movers & Shakers
Meet Dr. Renee Wegrzyn, the first Director of President Biden's new health agency, ARPA-H

Today's podcast guest, Dr. Renee Wegrzyn, directs ARPA-H, a new agency formed last year to spearhead health innovations. Time will tell if ARPA-H will produce advances on the level of its fellow agency, DARPA.

Adobe Stock

In today’s podcast episode, I talk with Renee Wegrzyn, appointed by President Biden as the first director of a health agency created last year, the Advanced Research Projects Agency for Health, or ARPA-H. It’s inspired by DARPA, the agency that develops innovations for the Defense department and has been credited with hatching world-changing technologies such as ARPANET, which became the internet.

Time will tell if ARPA-H will lead to similar achievements in the realm of health. That’s what President Biden and Congress expect in return for funding ARPA-H at 2.5 billion dollars over three years.

Listen on Apple | Listen on Spotify | Listen on Stitcher | Listen on Amazon | Listen on Google

How will the agency figure out which projects to take on, especially with so many patient advocates for different diseases demanding moonshot funding for rapid progress?

I talked with Dr. Wegrzyn about the opportunities and challenges, what lessons ARPA-H is borrowing from Operation Warp Speed, how she decided on the first ARPA-H project that was announced recently, why a separate agency was needed instead of reforming HHS and the National Institutes of Health to be better at innovation, and how ARPA-H will make progress on disease prevention in addition to treatments for cancer, Alzheimer’s and diabetes, among many other health priorities.

Dr. Wegrzyn’s resume leaves no doubt of her suitability for this role. She was a program manager at DARPA where she focused on applying gene editing and synthetic biology to the goal of improving biosecurity. For her work there, she received the Superior Public Service Medal and, in case that wasn’t enough ARPA experience, she also worked at another ARPA that leads advanced projects in intelligence, called I-ARPA. Before that, she ran technical teams in the private sector working on gene therapies and disease diagnostics, among other areas. She has been a vice president of business development at Gingko Bioworks and headed innovation at Concentric by Gingko. Her training and education includes a PhD and undergraduate degree in applied biology from the Georgia Institute of Technology and she did her postdoc as an Alexander von Humboldt Fellow in Heidelberg, Germany.

Dr. Wegrzyn told me that she’s “in the hot seat.” The pressure is on for ARPA-H especially after the need and potential for health innovation was spot lit by the pandemic and the unprecedented speed of vaccine development. We'll soon find out if ARPA-H can produce gamechangers in health that are equivalent to DARPA’s creation of the internet.

Show links:

ARPA-H - https://arpa-h.gov/

Dr. Wegrzyn profile - https://arpa-h.gov/people/renee-wegrzyn/

Dr. Wegrzyn Twitter - https://twitter.com/rwegrzyn?lang=en

President Biden Announces Dr. Wegrzyn's appointment - https://www.whitehouse.gov/briefing-room/statement...

Leaps.org coverage of ARPA-H - https://leaps.org/arpa/

ARPA-H program for joints to heal themselves - https://arpa-h.gov/news/nitro/ -

ARPA-H virtual talent search - https://arpa-h.gov/news/aco-talent-search/

Dr. Renee Wegrzyn was appointed director of ARPA-H last October.

Matt Fuchs
Matt Fuchs is the host of the Making Sense of Science podcast and served previously as the editor-in-chief of Leaps.org. He writes as a contributor to the Washington Post, and his articles have also appeared in the New York Times, WIRED, Nautilus Magazine, Fortune Magazine and TIME Magazine. Follow him @fuchswriter.
Big Questions

Vaccine Passports Are a Premature Solution to A Challenging Problem

OPINION ESSAY Big Questions
Vaccine Passports Are a Premature Solution to A Challenging Problem

Vaccine passports, if required by businesses and universities, may give people a false sense of security, one expert cautions.

Photo by CDC on Unsplash

Vaccines are one of the greatest public health accomplishments of all time. For centuries, public health has relied on vaccinations to prevent and control disease outbreaks for a plethora of infectious scourges, with our crowning achievement being the successful eradication of smallpox.

The purpose of vaccine documentation is to provide proof of an individual's protection from either becoming infected or transmitting a vaccine-preventable disease. Vouching for these protections requires a firm knowledge about the epidemiology of the disease, as well as scientific knowledge concerning the efficacy of the vaccine. The vaccines we currently require be documented have met these tests; the vaccine for COVID-19 has not yet been proven to do so.

Keep Reading Keep Reading
Georges C. Benjamin
Georges C. Benjamin, MD, is a well-known health policy leader, practitioner and administrator. He currently serves as the executive director of the American Public Health Association, the nation's oldest and largest organization of public health professionals. He is also a former secretary of health for the state of Maryland. Dr. Benjamin is a graduate of the Illinois Institute of Technology and the University Of Illinois College Of Medicine. He is board-certified in internal medicine, a Master of the American College of Physicians, a fellow of the National Academy of Public Administration, a fellow emeritus of the American College of Emergency Physicians, and a member of the National Academy of Medicine. He serves on several nonprofit boards such as Research!America, the Truth Foundation and, the Reagan-Udall Foundation. He is also a former member of the National Infrastructure Advisory Council, a council that advises the President on how best to assure the security of the nation’s critical infrastructure.
Big Questions

Are Vaccine Passports Ethical? Yes, As Long As No One Is Left Behind

OPINION ESSAY Bioethics
Are Vaccine Passports Ethical? Yes, As Long As No One Is Left Behind

A digital health passport required by businesses and universities could help us get back to normal more quickly, one expert argues.

Photo by Lukas on Unsplash

"Vaccine passports" are a system that requires proof of a COVID-19 vaccination as a condition of engaging in activities that pose a risk of transmitted SARS-CoV-2. Digital Health Passes (DHPs) are typically a smartphone application with a code that verifies whether someone has been vaccinated.

Vaccine passports could very much be in our future. Many businesses are implementing or planning to require proof of vaccination as a condition of returning to the workplace. Colleges and universities have announced vaccine requirements for students, staff, and faculty. It may not be long before the private sector requires a vaccination card or image to attend an entertainment or sporting event, to travel, or even to dine or shop indoors, at least in some venues.

Keep Reading Keep Reading
Lawrence O. Gostin
Lawrence O. Gostin is University Professor, Georgetown University’s highest academic rank, and Founding O’Neill Chair in Global Health Law. He directs the World Health Organization Center on National and Global Health Law. Gostin is Professor of Medicine at Georgetown University and Professor of Public Health at Johns Hopkins University. You can follow him on Twitter @lawrencegostin.